All Stories

  1. Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges
  2. Liposome-coated lipoplex–based carrier for antisense oligonucleotides
  3. Membrane Rafts in the Erythrocyte Membrane: A Novel Role of MPP1p55
  4. A novel L1340P mutation in theANK1gene is associated with hereditary spherocytosis?
  5. Upregulated expression and activation of membrane‑associated proteases in esophageal squamous cell carcinoma
  6. Membrane rafts as a novel target in cancer therapy
  7. Spectrins: A structural platform for stabilization and activation of membrane channels, receptors and transporters
  8. The role of MPP1/p55 and its palmitoylation in resting state raft organization in HEL cells
  9. Release of an ∼55kDa fragment containing the actin-binding domain of β-spectrin by caspase-8 during FND-induced apoptosis depends on the presence of protein 4.1
  10. microRNAs: fine tuning of erythropoiesis
  11. Human DHHC proteins: A spotlight on the hidden player of palmitoylation
  12. Key Amino Acid Residues of Ankyrin-Sensitive Phosphatidylethanolamine/Phosphatidylcholine-Lipid Binding Site of βI-Spectrin
  13. Magnetic field 50 Hz: Its influence on living cells HL-60: Basic tests which have a practical application
  14. The role of hydrophobic interactions in ankyrin–spectrin complex formation
  15. Do we already know how spectrin attracts ankyrin?
  16. Aggregation of spectrin and PKCθ is an early hallmark of fludarabine/mitoxantrone/dexamethasone-induced apoptosis in Jurkat T and HL60 cells
  17. The effect of the lipid-binding site of the ankyrin-binding domain of erythroid β-spectrin on the properties of natural membranes and skeletal structures
  18. A Raft-Associated Species of Phosphatidylethanolamine Interacts with Cholesterol Comparably to Sphingomyelin. A Langmuir-Blodgett Monolayer Study
  19. Phospholipid-induced structural changes to an erythroid β spectrin ankyrin-dependent lipid-binding site
  20. The 22.5kDa spectrin-binding domain of ankyrinR binds spectrin with high affinity and changes the spectrin distribution in cells in vivo
  21. Liposomal formulation of 5-fluorocytosine in suicide gene therapy with cytosine deaminase – for colorectal cancer
  22. Chapter Four Interactions of Erythroid and Nonerythroid Spectrins and Other Membrane-Skeletal Proteins with Lipid Mono- and Bilayers
  23. Higly fusogenic cationic liposomes transiently permeabilize the plasma membrane of HeLa cells
  24. Structural insight into an ankyrin-sensitive lipid-binding site of erythroid β-spectrin
  25. Spectrin–phospholipid interactions
  26. (AC)n microsatellite polymorphism and 14-nucleotide deletion in exon 42 ankyrin-1 gene in several families with hereditary spherocytosis in a population of South-Western Poland
  27. PS exposure increases the susceptibility of cells to fusion with DOTAP liposomes
  28. Synthetic Vectors for Genetic Drug Delivery
  29. Mitoxantrone changes spectrin-aminophospholipid interactions
  30. Cholesterol affects spectrin–phospholipid interactions in a manner different from changes resulting from alterations in membrane fluidity due to fatty acyl chain composition
  31. Changes in spectrin organisation in leukaemic and lymphoid cells upon chemotherapy
  32. Mapping of an ankyrin-sensitive, phosphatidylethanolamine/phosphatidylcholine mono- and bi-layer binding site in erythroid β-spectrin
  33. Proteins with Spectrin Motifs Which Do Not Belong to the Spectrin-α-Actinin- Dystrophin Family
  34. A protein isolated from Escherichia coli, identified as GroEL, reacts with anti-β spectrin antibodies
  35. Occurrence of lipid receptors inferred from brain and erythrocyte spectrins binding NaOH-extracted and protease-treated neuronal and erythrocyte membranes
  36. Brain spectrin exerts much stronger effect on anionic phospholipid monolayers than erythroid spectrin
  37. The domain of brain β-spectrin responsible for synaptic vesicle association is essential for synaptic transmission
  38. Spectrin (βSpIIΣ1) is an essential component of synaptic transmission
  39. Brain spectrin (fodrin) interacts with phospholipids as revealed by intrinsic fluorescence quenching and monolayer experiments
  40. Effect of dihydralazine on the fluidity of erythrocyte membranes
  41. ADP-ribosylation factor (ARF) regulates cAMP synthesis in potato
  42. Interaction of brain spectrin (fodrin) with phospholipids
  43. ARF-Protein Antisense Potato Displays Stable ADP-Ribosylation of 40 kDa Protein
  44. Ankyrin inhibits binding of erythrocyte spectrin to phospholipid vesicles
  45. Effect of hemin on growth and DNA synthesis of HL-60 cells
  46. Does a Prototype Scaffold/Matrix-Attached Region (SAR Sequence) Affect Intrinsic Nuclear Matrix Endonuclease Specificity?
  47. Does the Nuclear Matrix Endonuclease Show Specificity towards DNA Topoisomers?
  48. The effect of annexin IV and VI on the fluidity of phosphatidylserine/phosphatidylcholine bilayers studied with the use of 5-deoxylstearate spin label
  49. The effect of synapsin I phosphorylation upon binding of synaptic vesicles to spectrin
  50. Brain spectrin(240/235A): A novel astrocyte specific spectrin isoform
  51. The effect of nonadec(en)ylresorcinol on the fluidity of liposome and erythrocyte membranes
  52. Interaction of spectrin with phospholipids. Quenching of spectrin intrinsic fluorescence by phospholipid suspensions
  53. Labelling of erythrocyte spectrin in situ with phenylisothiocyanate
  54. Fluorescent labelling of proteins on thin layers of solid dansyl chloride